HB870

2026 Regular Session

HB870 by Representative Christopher Turner

INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (OR NO IMPACT See Note)

Current Status: Pending House floor action

Text

House Committee Amendment #3003 INS Proposed

House Committee Amendment #1540 INS Draft

Digest of HB870 Original

Fiscal Note - HB870 Original

Christopher Turner (primary)

Date	Chamber	Journal Page	Action
04/01	H		Reported with amendments (10-0).
03/09	H	105	Read by title, under the rules, referred to the Committee on Insurance.
02/27	H		First appeared in the Interim Calendar on 2/27/2026.
02/27	H		Under the rules, provisionally referred to the Committee on Insurance.
02/27	H		Prefiled.